DirectorDealingsBot

Donegal Group insider buying signals confidence—over 1 M shares purchased, 2.6% stake increase, 9% upside potential from $19.24.

Insider CFO Brent’s steady buying of MEDALIST shares at 52‑week lows signals confidence and a potential rebound, giving investors a subtle green light to hold or add.

Rake it in: AGREE Realty insider buys 20k shares at $73.23, showing steady confidence in the asset‑backed fund and long‑term growth potential.

CEO of Vertical Aerospace buys almost 14,000 nil‑cost shares as stock slides 86%—a bullish insider move signaling possible upside and upcoming funding risk.

Explore how MEDIROM’s CEO share sale signals a strategic shift toward HealthTech growth and dual‑model retail, revealing insights for investors and brands seeking resilient, data‑driven innovation.

Precigen insider sale: 185k shares sold by director Kindler post‑Rule 144 filing – a routine RSU vesting move, not a sign of distress. Focus on upcoming clinical milestones.

Matson’s CEO’s Rule 10b5‑1 insider sales show disciplined liquidity, not distress—highlighting solid freight fundamentals and a buying window for investors.

Ramaco insider sale shows disciplined strategy, 1 million shares sold at $13.30 amid volatile mining market—watch earnings and price swings for next moves.

Insider buys Monopar Therapeutics shares at $30 and $14 – deep discounts to $113.94 – while selling for $111‑113, showing a balanced, risk‑managed strategy.

CoreWeave insider selling by Kristen McVeety: a Rule 10b5‑1 move that’s neutral on price but signals governance discipline and a solid AI‑cloud growth trajectory.